These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34659108)

  • 1. Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia.
    Höppner J; Lais S; Roll C; Wegener-Panzer A; Wieczorek D; Högler W; Grasemann C
    Front Endocrinol (Lausanne); 2021; 12():700612. PubMed ID: 34659108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
    Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
    Grant MP; Stepanchick A; Breitwieser GE
    Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal features and neonatal management of severe hyperparathyroidism caused by the heterozygous inactivating calcium-sensing receptor variant, Arg185Gln: A case report and review of the literature.
    Aubert-Mucca M; Dubucs C; Groussolles M; Vial J; Le Guillou E; Porquet-Bordes V; Pasmant E; Salles JP; Edouard T
    Bone Rep; 2021 Dec; 15():101097. PubMed ID: 34169121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinacalcet therapy in a child with novel homozygous CASR p.Glu353Lys mutation causing familial hypocalciuric hypercalcemia type 1: case report and review of the literature.
    Koca SB
    Turk J Pediatr; 2023; 65(5):853-861. PubMed ID: 37853976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorders of the Calcium Sensing Signaling Pathway: From Familial Hypocalciuric Hypercalcemia (FHH) to Life Threatening Conditions in Infancy.
    Höppner J; Sinningen K; Raimann A; Obermayer-Pietsch B; Grasemann C
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
    Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
    Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
    Watanabe S; Fukumoto S
    Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene.
    Cole DE; Janicic N; Salisbury SR; Hendy GN
    Am J Med Genet; 1997 Aug; 71(2):202-10. PubMed ID: 9217223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of primary hyperparathyroidism.
    Brown EM
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
    Marx SJ
    J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation.
    Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
    Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
    Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
    Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
    Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.
    Zajíčková K; Dvořáková M; Moravcová J; Včelák J; Goltzman D
    Physiol Res; 2020 Sep; 69(Suppl 2):S321-S328. PubMed ID: 33094630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homozygous CaSR mutation causing a FHH phenotype completely masked by vitamin D deficiency presenting as rickets.
    Szczawinska D; Schnabel D; Letz S; Schöfl C
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1146-53. PubMed ID: 24517148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
    Mahajan A; Buse J; Kline G
    Osteoporos Int; 2020 Jan; 31(1):203-207. PubMed ID: 31641801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
    Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
    Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.